Also trades as: WGSWW (NASDAQ) · $vol 0M
WGS NASDAQ
GeneDx Holdings Corp.
1W: -2.4%
1M: +3.5%
3M: +39.8%
YTD: -35.5%
1Y: -30.8%
3Y: +1833.6%
5Y: -73.9%
$85.27
+1.30 (+1.55%)
Weekly Expected Move ±5.6%
$76
$80
$85
$90
$95
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Bullish
75
Insider+$93.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.5B
52W Range32.21-170.87
Volume331,591
Avg Volume1,152,642
Beta2.01
Dividend—
Analyst Ratings
Company Info
CEOKatherine A. Stueland
Employees1,300
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2020-11-04
Websitegenedx.com
North Tower
Stamford, CT 06902
US
Stamford, CT 06902
US
800 298 6470
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Stueland Katherine | M-Exempt | 6,547 | — | 2026-09-09 |
| Stueland Katherine | S-Sale | 3,692 | $84.22 | 2026-09-09 |
| Stueland Katherine | M-Exempt | 6,547 | — | 2026-09-09 |
| Feeley Kevin | M-Exempt | 2,462 | — | 2026-09-09 |
| Feeley Kevin | S-Sale | 1,285 | $84.22 | 2026-09-09 |